Company Filing History:
3 out of 328 
1 out of 559 
1 out of 265 
Years Active: 2016-2021
Title: Maria Contel: Innovator in Cancer Therapy
Introduction
Maria Contel is a prominent inventor based in Brooklyn, NY (US). She has made significant contributions to the field of cancer therapy, holding a total of 3 patents. Her innovative work focuses on antibody-drug conjugates and their applications in treating various types of cancer.
Latest Patents
One of her latest patents involves antibody-drug conjugates based on gold compounds. These ADCs are designed with a specific structure where the drug moieties are bound to the Trastuzumab antibody, achieving a drug-to-antibody ratio (DAR) between 2 and 4. This innovative approach is particularly useful in treating breast cancer. Another notable patent features arene ruthenium (II) derivatives containing iminophosphorane ligands. This method provides a therapeutic benefit for subjects with cancer by administering a compound that includes an arene ruthenium (II) compound with an iminophosphorane ligand.
Career Highlights
Maria has worked with esteemed institutions such as the City University of New York and Memorial Sloan Kettering Cancer Center. Her experience in these organizations has allowed her to advance her research and contribute to the development of effective cancer therapies.
Collaborations
Throughout her career, Maria has collaborated with notable colleagues, including Benelita T Elie and Natalia Curado. These partnerships have further enriched her research and innovation in the field.
Conclusion
Maria Contel's work exemplifies the impact of innovative thinking in cancer therapy. Her patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.